Project Grant R21AI199588
- Federal Grant Award Summary The University of Illinois received a $154,052 Project Grant award dated August 5, 2025, from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The research project, entitled "Role of Arginine as a Metabolic Cue During Enteric Infection," will be conducted in Illinois through July 31, 2027. The award supports investigator-initiated biomedical research aimed at...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Illinois a Project Grant totaling $736,822 under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 1, 2026, through January 31, 2031. This award supports investigator-initiated biomedical research examining bacterial lipases and adaptation to the host lipid environment, with performance at the Chicago, Illinois campus. The research...
- Federal Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Wisconsin–Madison a $427,625 Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) for the period February 2, 2026, through January 31, 2028. This award funds investigator-initiated biomedical research to define the role of the YEIH protein in Salmonella pathogenesis, specifically examining how this bacterial protein contributes to resistance...
- Federal Project Grant Award Summary The University of Illinois received a $2.84M Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 7, 2025, for completion by June 30, 2029. This research initiative focuses on bacterial cell wall remodeling, innate immunity, and pathogenesis mechanisms in Staphylococcus aureus infections. The project examines how staphylococcal...
- Federal Grant Award Summary The University of Illinois received a $1.14 million Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective August 1, 2025, through July 31, 2030. This award funds research to identify physicochemical traits that enable small molecule compounds to evade efflux pump mechanisms in gram-negative bacteria. The research will measure accumulation of...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded the Regents of the University of Colorado–Denver a $2.73M Project Grant under the Allergy and Infectious Diseases Research program (CFDA 93.855) effective September 4, 2025, with completion targeted for August 31, 2029. This four-year research initiative examines phage-salmonella interactions during oxidative stress, with the overarching objective of elucidating mechanisms by which...
- Federal Grant Award Summary The University of Illinois received a $582,350 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded July 8, 2025, with completion targeted for June 30, 2030. The grant funds investigator-initiated research to identify microbiota-mediated colonization resistance mechanisms against Acinetobacter baumannii, a multidrug-resistant pathogen that poses...
- Federal Project Grant Award Summary The University of Illinois at Chicago received a $585,539 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), awarded September 4, 2025, with a completion date of August 31, 2030. This research initiative investigates Acinetobacter baumannii carbon metabolism during intermicrobial competition in the gastrointestinal tract. The project will develop and...
- Federal Project Grant Award Summary The National Institute of Allergy and Infectious Diseases (NIAID) awarded $109,476 to the University of Wisconsin-Madison under the Allergy and Infectious Diseases Research program (CFDA 93.855) on November 30, 2025, with a completion date of May 31, 2027. This Project Grant supports fundamental research to understand the molecular mechanisms governing drug efflux in bacterial multidrug resistance transporters, specifically the NorA pump. The research...
- Federal Project Grant Award Summary The University of Texas Southwestern Medical Center received a $596,318 Project Grant from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), effective February 10, 2026, through January 31, 2031. The award supports research on virulence factor functions in non-typhoidal Salmonella typhimurium, focusing on understanding how bacterial pathogens manipulate host defense...
The National Institute of Allergy and Infectious Diseases (NIAID) awarded the University of Illinois a Project Grant totaling $186,711 under the Allergy and Infectious Diseases Research program (CFDA 93.855) to conduct investigator-initiated basic science research on polyamine biosynthesis regulation in Salmonella typhimurium. The research, performed at the University of Illinois location in Urbana, Illinois, and scheduled for completion by March 31, 2028, focuses on understanding how bacterial cells coordinately control polyamine and magnesium concentrations during infection and stress responses. The project directly addresses fundamental mechanisms of bacterial pathogenesis, as Salmonella typhimurium is a major food-borne pathogen that must adapt to the low-magnesium environment within macrophage phagosomes for successful intracellular replication and virulence. The grant supports basic research activities designed to elucidate the regulatory mechanisms governing polyamine synthesis and export in bacteria, with specific emphasis on the role of the PhoP signal transduction system. Deliverables include scientific findings that advance understanding of how polyamines function as physiological substitutes for magnesium under nutrient stress conditions, research data characterizing polyamine mutant phenotypes, and mechanistic insights into coordinated control of polyamine and magnesium homeostasis during bacterial infection. The University of Illinois, as an established research institution with extensive federal grant experience, leverages its expertise in bacterial genetics and gene expression analysis to address these fundamental questions critical to infectious disease biology and pathogen virulence mechanisms.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $186.7k | 4/27/26 |